Janaxa Pharmaceuticals Private Limited, a active private limited company, was established on 07 June 2012 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232CH2012PTC033849. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Formerly known as Lab Corp India Private Limited. It upholds a compliant status. Its leadership includes Manoj Kumar (Director), Rahul Khosla (Director). Past directors included Vikas Sharma, Vivek Singla, Manoj Kumar. It holds ₹9.50 M open charges and ₹1.95 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 501, First & Second Floor Motor Market, Manimajra, Chandigarh, Chandigarh, 160101.
U24232CH2012PTC033849
033849
07 June 2012
₹1.00 M
₹1.00 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Janaxa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Kumar | Director | 13 Jan 2014 | Current |
| Rahul Khosla | Director | 07 Jun 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Dec 2015 | Past |
| Pramod Abcsdd | Director | 03 Dec 2015 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2014 | Past |
| Pramod Abcsdd | Director | 01 Nov 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Janaxa Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.26% increase. The company also saw a substantial improvement in profitability, with a 29.77% increase in profit. The company's net worth Soared by an impressive increase of 24.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Janaxa Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,500,000.00
₹1,950,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jan 2024 | Hdfc Bank Limited | ₹6.00 M | Open |
| 11 Jan 2022 | Hdfc Bank Limited | ₹3.50 M | Open |
| 06 Oct 2021 | Others | ₹1.00 M | Satisfied |
| 03 May 2019 | Others | ₹0.95 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Janaxa Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Janaxa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Janaxa Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited of Rs. 6.00 M registered on 15 Jan 2024 with Charge ID 100868568 was modified on 24 Oct 2024. was completed.
The activity Janaxa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge registered on 06 Oct 2021 via Charge ID 100495289 with Others was fully satisfied on 20 Aug 2024. was documented.
A charge registered on 03 May 2019 via Charge ID 100270168 with Others was fully satisfied on 22 May 2024. was recorded as a recent event.
The activity Janaxa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 6.00 M with Charge ID 100868568 was registered on 15 Jan 2024. was documented.
The CIN of Janaxa Pharmaceuticals Private Limited is U24232CH2012PTC033849.
Janaxa Pharmaceuticals Private Limited is headquartered at Sco 501, First & Second Floor Motor Market, Manimajra, Chandigarh, Chandigarh, 160101.
Janaxa Pharmaceuticals Private Limited was incorporated on 07 June 2012.
The current directors of Janaxa Pharmaceuticals Private Limited are
The primary industry of Janaxa Pharmaceuticals Private Limited is Trade.
Janaxa Pharmaceuticals Private Limited is unlisted.
The authorized capital of Janaxa Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Janaxa Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX